THE LEVEL OF SYSTEMIC INFLAMMATION AND THE STATE OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CORONARY HEART DISEASE WITH METABOLIC SYNDROME


  • S.V. Shut Ukrainian Medical Stomatological Academy, Ukraine
  • N.I. Chekalina Ukrainian Medical Stomatological Academy, Ukraine
  • T.A. Trybrat Ukrainian Medical Stomatological Academy, Ukraine
  • V.D. Sakevych Ukrainian Medical Stomatological Academy, Ukraine
  • V.P. Boriak Ukrainian Medical Stomatological Academy, Ukraine
Keywords: coronary heart disease, metabolic syndrome, chronic systemic inflammation, cytokines, central hemodynamics.

Abstract

THE LEVEL OF SYSTEMIC INFLAMMATION AND THE STATE OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CORONARY HEART DISEASE WITH METABOLIC SYNDROME

References

1. Shi, A., Tao, Z., Wei, P.& Zhao, J.,2016.Epidemiological aspects of heart. Exp Ther Med diseases.12(3), pp. 1645–1650.

2. Galkina, E.&Ley, K., 2009. Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol. 27, pp. 165–197.

3. Ridker, P.M., Howard, C.P., Walter, V., Everent, B., Libby, P., Hensen, J. &Thuren T., 2012. Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactiveprotein, interleukin-6, andfibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation. 126(23), pp. 2739-2748.

4. Hashizume, M. & Mihara M., 2012. Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors. Cytokine. 58(3), pp. 424–430.

5. Hedrick, C.C., 2015. Lymphocytes in Atherosclerosis. Arterioscler Thromb Vasc Biol. 35(2), pp. 253–257.

6. Galenko-Iaroshevsky, P.A., Sukoyan, G.V., Ionov, D.I., Zelenskaya, A.V. &Khvitia N.G., 2017. Possibility of inhibition of TNF-α/NF-kB signaling pathway activation in myocardium and reverse cardiac hemodynamics in chronic ischemic heart disease J ClinExpPathol. 7(3). DOI: 10.4172/2161-0681.1000310

7. Evangelista, A., Flachskampf, F., Lancellotti, P., Badano, L., Aquilar, R., Monaghan, M., Zamorano, J. & Nihoyannopoulos, P., 2008. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr. 9, pp. 438-448.

8. A gluco-metabolic risk index with cardiovascular risk stratification potential in patients with coronary artery disease / M. Anselmino, K. Malmberg, L. Ryden, J. Ohrvik // DiabVasc Dis Res. – 2009. – №6 (2). – P.62-70.

9. Behrendt D. Endothelial function. From vascular biology to clinical applications / D. Behrendt, P. Ganz // Amer. J. Cardiol. – 2002. – V.21. – P.40–48.
Published
2019-11-07
How to Cite
Shut, S., Chekalina, N., Trybrat, T., Sakevych, V., & Boriak, V. (2019). THE LEVEL OF SYSTEMIC INFLAMMATION AND THE STATE OF CENTRAL HEMODYNAMICS IN PATIENTS WITH CORONARY HEART DISEASE WITH METABOLIC SYNDROME. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 3(1), 93-94. https://doi.org/10.29256/v.03.01.2019.escbm63
Section
Selected abstracts